focus -WSS

focus

author：entertainment 2025-09-28 02:28:15 - browse：38

Methadone and buprenorphine, both FDA-approved drugs, are considered the gold standard for treating opioid use disorder. They are so effective, in fact, that they are considered nearly curative for people who use them as prescribed. But a multitude of social and physical barriers to access mean that only about 20% of people who could benefit from these medicines have access to them. Access is even harder for pregnant people, who face additional stigmas and challenges.

Arthur Robin Williams, an addiction psychiatrist, and Judith Cole, a nurse practitioner, join the podcast this week to speak about the challenges during pregnancy, including the reality that federal law makes it possible for child protective services to be called when people receiving legal effective treatments for addiction give birth. Despite medications like methadone being fully safe during pregnancy, they continue to carry a stigma that can result in trauma for both birth parents and newborns.

“What’s getting conflated here is a result on a drug test, for instance, with actual abuse or neglect,” said Williams.

Williams and Cole wrote about this issue in their recent First Opinion essay, “Mothers in treatment for opioid use disorder shouldn’t also have to fight child protective services.” You can read more about barriers to addiction treatment in STAT reporter Lev Facher’s series “The War on Recovery.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Fauci's latest grilling in Congress: 9 hours, behind closed doors

Wikipedia

WSS

A preacher's new calling: Diversifying neuroscience research

JPM pitch from hospitals? Revenue streams outside of patient care

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

NEJM study link tiny plastics in blood vessels to heart problems

Precocious puberty in girls comes with mental health risks

focus

focus

hotspot

Supreme Court strikes down use of affirmative action

Allen Institute goes after foundational questions, CEO Costa says

Dobbs anniversary: the lost opportunity of abortion as health care

Novo Nordisk obesity pill bests Wegovy in early trial

What does generative AI mean for health care? We asked experts

Medicare Advantage coverage denials need scrutiny, senators say

How one medical school became remarkably diverse

Amylyx ALS drug fails large clinical trial

Heart attack and stroke risk calculators need revising

American taxpayers paid $1.8 trillion in health care costs in 2022

focus

Allen Institute goes after foundational questions, CEO Costa says

Hospital chaplains balance Covid safety with patients’ spiritual needs

CDC marks new Covid

STAT Virtual Event: JPM Recap, Live!

Headspace, Meta partner to launch VR meditation app for Quest

Medicare Advantage coverage denials need scrutiny, senators say

Wikipedia

focus

explore

entertainment